Refuge Biotechnologies, Inc., Menlo Park, CA, United States.
Essa Pharmaceuticals, Inc. South San Francisco, CA, United States.
Front Immunol. 2021 Jan 27;11:604967. doi: 10.3389/fimmu.2020.604967. eCollection 2020.
In recent years, cancer immunotherapy experienced remarkable developments and it is nowadays considered a promising therapeutic frontier against many types of cancer, especially hematological malignancies. However, in most types of solid tumors, immunotherapy efficacy is modest, partly because of the limited accessibility of lymphocytes to the tumor core. This immune exclusion is mediated by a variety of physical, functional and dynamic barriers, which play a role in shaping the immune infiltrate in the tumor microenvironment. At present there is no unified and integrated understanding about the role played by different postulated models of immune exclusion in human solid tumors. Systematically mapping immune landscapes or "topographies" in cancers of different histology is of pivotal importance to characterize spatial and temporal distribution of lymphocytes in the tumor microenvironment, providing insights into mechanisms of immune exclusion. Spatially mapping immune cells also provides quantitative information, which could be informative in clinical settings, for example for the discovery of new biomarkers that could guide the design of patient-specific immunotherapies. In this review, we aim to summarize current standard and next generation approaches to define Cancer Immune Topographies based on published studies and propose future perspectives.
近年来,癌症免疫疗法取得了显著的发展,目前被认为是对抗多种癌症(尤其是血液系统恶性肿瘤)的一种有前途的治疗方法。然而,在大多数类型的实体肿瘤中,免疫疗法的疗效有限,部分原因是淋巴细胞难以进入肿瘤核心。这种免疫排斥是由多种物理、功能和动态屏障介导的,这些屏障在塑造肿瘤微环境中的免疫浸润方面发挥了作用。目前,对于不同假设的免疫排斥模型在人类实体肿瘤中所起的作用,还没有统一和综合的认识。系统地绘制不同组织学癌症的免疫图谱或“地形”对于描述肿瘤微环境中淋巴细胞的时空分布至关重要,这为免疫排斥机制提供了深入的了解。对免疫细胞进行空间定位还提供了定量信息,这些信息在临床环境中可能具有重要意义,例如可以发现新的生物标志物,从而指导针对特定患者的免疫治疗方案的设计。在这篇综述中,我们旨在总结基于已发表研究的定义癌症免疫地形的当前标准和下一代方法,并提出未来的展望。